Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311358957> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4311358957 endingPage "S15" @default.
- W4311358957 startingPage "S15" @default.
- W4311358957 abstract "Larotrectinib and entrectinib are tumor-agnostic tropomyosin receptor kinase (TRK) inhibitors for the treatment of advanced or metastatic solid tumor cancers with neurotrophic tyrosine receptor kinase (NTRK) gene fusions. Regulatory approval of both agents was based on data from single-arm Phase 1/2 studies, including tumor-agnostic basket trials. In the absence of randomized controlled trials, there remains a paucity of data to demonstrate the comparative effectiveness of these agents. The objective was to extrapolate clinical trial results to compare estimated progression-free and overall life-years (LYs) and quality-adjusted LYs (QALYs) for larotrectinib and entrectinib in patients with colorectal cancer (CRC), soft tissue sarcoma (STS), and brain metastases (BM) at baseline." @default.
- W4311358957 created "2022-12-25" @default.
- W4311358957 creator A5000080366 @default.
- W4311358957 creator A5037114020 @default.
- W4311358957 creator A5056749886 @default.
- W4311358957 creator A5090370670 @default.
- W4311358957 date "2022-12-01" @default.
- W4311358957 modified "2023-09-27" @default.
- W4311358957 title "P62 Parametric Survival Extrapolations of Larotrectinib and Entrectinib for NTRK Fusion Cancers" @default.
- W4311358957 doi "https://doi.org/10.1016/j.jval.2022.09.074" @default.
- W4311358957 hasPublicationYear "2022" @default.
- W4311358957 type Work @default.
- W4311358957 citedByCount "0" @default.
- W4311358957 crossrefType "journal-article" @default.
- W4311358957 hasAuthorship W4311358957A5000080366 @default.
- W4311358957 hasAuthorship W4311358957A5037114020 @default.
- W4311358957 hasAuthorship W4311358957A5056749886 @default.
- W4311358957 hasAuthorship W4311358957A5090370670 @default.
- W4311358957 hasConcept C101544691 @default.
- W4311358957 hasConcept C121608353 @default.
- W4311358957 hasConcept C126322002 @default.
- W4311358957 hasConcept C134139212 @default.
- W4311358957 hasConcept C143998085 @default.
- W4311358957 hasConcept C170493617 @default.
- W4311358957 hasConcept C42362537 @default.
- W4311358957 hasConcept C502942594 @default.
- W4311358957 hasConcept C535046627 @default.
- W4311358957 hasConcept C71924100 @default.
- W4311358957 hasConcept C92020748 @default.
- W4311358957 hasConceptScore W4311358957C101544691 @default.
- W4311358957 hasConceptScore W4311358957C121608353 @default.
- W4311358957 hasConceptScore W4311358957C126322002 @default.
- W4311358957 hasConceptScore W4311358957C134139212 @default.
- W4311358957 hasConceptScore W4311358957C143998085 @default.
- W4311358957 hasConceptScore W4311358957C170493617 @default.
- W4311358957 hasConceptScore W4311358957C42362537 @default.
- W4311358957 hasConceptScore W4311358957C502942594 @default.
- W4311358957 hasConceptScore W4311358957C535046627 @default.
- W4311358957 hasConceptScore W4311358957C71924100 @default.
- W4311358957 hasConceptScore W4311358957C92020748 @default.
- W4311358957 hasIssue "12" @default.
- W4311358957 hasLocation W43113589571 @default.
- W4311358957 hasOpenAccess W4311358957 @default.
- W4311358957 hasPrimaryLocation W43113589571 @default.
- W4311358957 hasRelatedWork W1564928084 @default.
- W4311358957 hasRelatedWork W1990390456 @default.
- W4311358957 hasRelatedWork W2037831105 @default.
- W4311358957 hasRelatedWork W2040749893 @default.
- W4311358957 hasRelatedWork W2282636056 @default.
- W4311358957 hasRelatedWork W2907628865 @default.
- W4311358957 hasRelatedWork W2990849561 @default.
- W4311358957 hasRelatedWork W3026620415 @default.
- W4311358957 hasRelatedWork W4297944786 @default.
- W4311358957 hasRelatedWork W4311883962 @default.
- W4311358957 hasVolume "25" @default.
- W4311358957 isParatext "false" @default.
- W4311358957 isRetracted "false" @default.
- W4311358957 workType "article" @default.